Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    Open Studies | "Hypotrichosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypotrichosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Conditions: Post Radiation/Chemotherapy Alopecia Presents With Hair Thinning.;   Post-burn Alopecia Presents With Hair Thinning.;   Cicatricial Alopecia Presents With Hair Thinning.;   Androgenetic Alopecia Presents With Hair Thinning;   Alopecia Due to Traumatic Injuries Presents With Hair Thinning.;   Alopecia Due to Skin Disease Presents With Hair Thinning.
Intervention: Device: Anchoring system
2 Recruiting Minoxidil Response Testing in Females With Female Pattern Hair Loss
Conditions: Alopecia;   Female Pattern Hair Loss
Intervention: Drug: 5% minoxidil topical foam
3 Recruiting A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Condition: Androgenetic Alopecia
Interventions: Drug: SM04554;   Drug: Vehicle
4 Unknown  Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
Condition: Alopecia Areata
Interventions: Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
5 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
6 Unknown  Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
7 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Triamcinolone 2.5 mg/ml;   Drug: Triamcinolone 5 mg/ml;   Drug: Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
8 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
9 Unknown  Stem Cell Educator Therapy in Alopecia Areata
Condition: Alopecia Areata
Intervention: Device: Stem Cell Educator
10 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
11 Unknown  Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
12 Recruiting Minoxidil Response Testing in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Drug: 5% minoxidil topical foam
13 Recruiting Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib administration
14 Recruiting An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Condition: Alopecia Areata
Intervention: Drug: Tofacitinib
15 Recruiting Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Biological: PRP
16 Unknown  Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Intervention: Drug: Clobetasol Propionate 0.05% Emollient Foam
17 Recruiting The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
Condition: ALOPECIA AREATA
Intervention: Drug: Methotrexate
18 Unknown  The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
19 Unknown  Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition: Alopecia
Interventions: Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel
20 Recruiting Scalp Cooling to Prevent Chemo-induced Hair Loss
Conditions: Breast Cancer;   Alopecia
Interventions: Device: PAXMAN Orbis Scalp Cooler;   Other: Control No treatment

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years